Akari Therapeutics Plc Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Akari Therapeutics Plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Akari Therapeutics Plc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.9M, a 0.84% decline year-over-year.
  • Akari Therapeutics Plc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$23M.
  • Akari Therapeutics Plc annual Net Income (Loss) Attributable to Parent for 2023 was -$12.8M, a 2.01% increase from 2022.
  • Akari Therapeutics Plc annual Net Income (Loss) Attributable to Parent for 2022 was -$13.1M, a 24.9% increase from 2021.
  • Akari Therapeutics Plc annual Net Income (Loss) Attributable to Parent for 2021 was -$17.4M, a 2.01% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.